This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Spirito, P. Articles by Bruzzi, P. Search for Related Content PubMed PubMed Citation Articles by Spirito, P. Articles by Bruzzi, P. Pubmed/NCBI databases Medline Plus Health Information Cardiomyopathy Related Collections Other heart failure Cardiovascular Pharmacology

(Circulation. 1999;99:2132-2137.)
© 1999 American Heart Association, Inc.

Clinical Investigation and Reports

Infective Endocarditis in Hypertrophic Cardiomyopathy

Prevalence, Incidence, and Indications for Antibiotic Prophylaxis

Paolo Spirito, MD; Claudio Rapezzi, MD; Pietro Bellone, MD; Sandro Betocchi, MD; Camillo Autore, MD; Maria Rosa Conte, MD; Gian Paolo Bezante, MD; Paolo Bruzzi, MD, PhD

From the Divisione di Cardiologia, Ente Ospedaliero Ospedali Galliera, Genoa, (P.S.); Istituto di Malattie dell'Apparato Cardiovascolare, Università di Bologna, Policlinico Sant'Orsola, Bologna (C.R.); Divisione di Cardiologia, Ospedale Santa Corona, Pietra Ligure (P. Bellone); II Faculta di Medicina e Chirurgia, Università di Napoli (S.B); Dipartimento di Scienze Cardiovascolari e Respiratorie, Università La Sapienza, Rome (C.A.); Divisione di Cardiologia, Ospedale degli Infermi, Rivoli, Torino (M.R.C.); Cattedra di Cardiologia, Dipartimento di Medicina Interna, Università degli Studi, Genoa (G.P.B.); and Servizio di Epidemiologia Clinica, Istituto Nazionale per la Ricerca sul Cancro, Genoa (P. Bruzzi).

Correspondence to Paolo Spirito, MD, Divisione di Cardiologia, Ente Ospedaliero Ospedali Galliera, Via Volta 8, 16128 Genoa, Italy. E-mail p.spirito{at}galliera.it

Background—The literature on infective endocarditis in hypertrophic cardiomyopathy (HCM) is virtually confined to case reports. Consequently, the risk of endocarditis in HCM remains undefined.

Methods and Results—We assessed the occurrence of endocarditis in 810 HCM patients evaluated between 1970 and 1997. Endocarditis was diagnosed in 10 patients, 2 of whom were excluded from analysis of prevalence and incidence because they were referred for acute endocarditis. At first evaluation, echocardiographic features consistent with prior endocarditis were identified in 3 of 808 patients, a prevalence of 3.7 per 1000 patients (95% CI, 0.8 to 11). Of 681 patients who were followed, 5 developed endocarditis, an incidence of 1.4 per 1000 person-years (95% CI, 0.5 to 3.2); outflow obstruction was present in each of these 5 patients and was associated with the risk of endocarditis (P=0.006). In the 224 obstructive patients, incidence of endocarditis was 3.8 per 1000 person-years (95% CI, 1.6 to 8.9) and probability of endocarditis 4.3% at 10 years. Left atrial size was also associated with the risk of endocarditis (P=0.007). In patients with both obstruction and atrial dilatation (50 mm), incidence of endocarditis increased to 9.2 per 1000 person-years (95% CI, 2.5 to 23.5). Analysis of all 10 patients with endocarditis identified outflow obstruction in each and atrial dilatation in 7.

Conclusions—Endocarditis in HCM is virtually confined to patients with outflow obstruction and is more common in those with both obstruction and atrial dilatation. These results indicate that antibiotic prophylaxis is required only in patients with obstructive HCM.

Key Words: hypertrophy • cardiomyopathy • echocardiography

This article has been cited by other articles:

				T. Louahabi, A. Drighil, R. Habbal, and L. Azzouzi Infective endocarditis complicating hypertrophic obstructive cardiomyopathy Eur J Echocardiogr, December 1, 2006; 7(6): 468 - 470. [Abstract] [Full Text] [PDF]

				P M Elliott, J R Gimeno, R Thaman, J Shah, D Ward, S Dickie, M T Tome Esteban, and W J McKenna Historical trends in reported survival rates in patients with hypertrophic cardiomyopathy Heart, June 1, 2006; 92(6): 785 - 791. [Abstract] [Full Text] [PDF]

				P. Spirito and C. Autore Management of hypertrophic cardiomyopathy. BMJ, May 27, 2006; 332(7552): 1251 - 1255. [Full Text] [PDF]

				C. Autore, P. Bernabo, C. S. Barilla, P. Bruzzi, and P. Spirito The prognostic importance of left ventricular outflow obstruction in hypertrophic cardiomyopathy varies in relation to the severity of symptoms J. Am. Coll. Cardiol., April 5, 2005; 45(7): 1076 - 1080. [Abstract] [Full Text] [PDF]

				B. J. Maron, W. J. McKenna, G. K. Danielson, L. J. Kappenberger, H. J. Kuhn, C. E. Seidman, P. M. Shah, W. H. Spencer III, P. Spirito, F. J. Ten Cate, et al. American College of Cardiology/European Society of Cardiology Clinical Expert Consensus Document on Hypertrophic Cardiomyopathy: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the European Society of Cardiology Committee for Practice Guidelines J. Am. Coll. Cardiol., November 5, 2003; 42(9): 1687 - 1713. [Full Text] [PDF]

				Writing Committee Members, B. J. Maron, W. J. McKenna, G. K. Danielson, L. J. Kappenberger, H. J. Kuhn, C. E. Seidman, P. M. Shah, W. H. Spencer III, P. Spirito, et al. American College of Cardiology/European Society of Cardiology Clinical Expert Consensus Document on Hypertrophic Cardiomyopathy: A report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the European Society of Cardiology Committee for Practice Guidelines Eur. Heart J., November 1, 2003; 24(21): 1965 - 1991. [Full Text] [PDF]

				C. Autore, M. R. Conte, M. Piccininno, P. Bernabo, G. Bonfiglio, P. Bruzzi, and P. Spirito Risk associated with pregnancy in hypertrophic cardiomyopathy J. Am. Coll. Cardiol., November 20, 2002; 40(10): 1864 - 1869. [Abstract] [Full Text] [PDF]

				G Morgan-Hughes and J Motwani Mitral valve endocarditis in hypertrophic cardiomyopathy: case report and literature review Heart, June 1, 2002; 87(6): e8 - 8. [Abstract] [Full Text] [PDF]

				B. J. Maron Hypertrophic Cardiomyopathy: A Systematic Review JAMA, March 13, 2002; 287(10): 1308 - 1320. [Abstract] [Full Text] [PDF]

				B. J. Maron, I. Olivotto, P. Bellone, M. R. Conte, F. Cecchi, B. P. Flygenring, S. A. Casey, T. E. Gohman, S. Bongioanni, and P. Spirito Clinical profile of stroke in 900 patients with hypertrophic cardiomyopathy J. Am. Coll. Cardiol., January 16, 2002; 39(2): 301 - 307. [Abstract] [Full Text] [PDF]

				B. J. Maron, I. Olivotto, P. Spirito, S. A. Casey, P. Bellone, T. E. Gohman, K. J. Graham, D. A. Burton, and F. Cecchi Epidemiology of Hypertrophic Cardiomyopathy-Related Death : Revisited in a Large Non-Referral-Based Patient Population Circulation, August 22, 2000; 102(8): 858 - 864. [Abstract] [Full Text] [PDF]

				P. Spirito, P. Bellone, K. M. Harris, P. Bernabo, P. Bruzzi, and B. J. Maron Magnitude of Left Ventricular Hypertrophy and Risk of Sudden Death in Hypertrophic Cardiomyopathy N. Engl. J. Med., June 15, 2000; 342(24): 1778 - 1785. [Abstract] [Full Text] [PDF]